Biomarkers US: In-Person

: Speakers

Speakers

03 - 04 October 2022 | San Diego, USA

+ Digital Day: 05 October 2022 | Online

Attracting leading experts & the brightest minds in the industry to educate, inform and excite our attendees.

The following are confirmed speakers for Biomarkers & Immuno US: In-Person 2022

Alekhya Pochiraju

Alekhya Pochiraju

Product Development, Global Operations Manager

Genentech

Alex Cao

Alex Cao

Executive Director, Oncology Clinical Biomarker Support

Merck & Co.

Anand Giddabasappa

Anand Giddabasappa

Head of Global Science and Technology, Comparative Medicine

Pfizer

Andrew Allen

Andrew Allen

Co-Founder, President and Chief Executive Officer

Gritstone Oncology

Antonio Santidrian

Antonio Santidrian

Vice President Research & Development and Translational Oncology

Calidi Biotherapeutics

Arnaud Amzallag

Arnaud Amzallag

Senior Principal Scientist

Bristol-Myers Squibb

Aude-Helene Capietto

Aude-Helene Capietto

Senior Scientific Researcher, Cancer Immunology Department

Genentech

Bonnie Hammer

Bonnie Hammer

Vice President, Biologics Development

Invenra

Catherine Aversa-Fleener

Catherine Aversa-Fleener

Senior Director, Translational Biology

Xencor

Chih-Liang Chin

Chih-Liang Chin

Executive Director, Pacific Translational Biomarkers

Merck & Co.

Christie Fanton

Christie Fanton

Executive Director, Translational Research

Nektar Therapeutics

Chrystal Paulos

Chrystal Paulos

Director of Translational Research, Melanoma & Cutaneous Malignancies

Emory University

Dan Passeri

Dan Passeri

President & CEO

Cue Biopharma

Dave Hoon

Dave Hoon

Professor, Director

St.John's Cancer Institute

Diana Price

Diana Price

Executive Director, Biosciences

Neuropore Therapeutics

Dimitrios Mathios

Dimitrios Mathios

Neurosurgery Chief Resident

Johns Hopkins University, School of Medicine

Ewa Carrier

Ewa Carrier

Executive Director, Clinical Development

Fibrogen

Ezinneka Imoh

Ezinneka Imoh

Senior Manager, Oncology Scientific Communications, Global Medical & Scientific Affairs

Karyopharm Therapeutics Inc.

George Poste

George Poste

Regents Professor

Arizona State University

Graham Jones

Graham Jones

Director of Innovation

Novartis

Hong Lin

Hong Lin

Head of Clinical Immunology/Flow Cytometry

Stony Brook University

Hua Eleanor Yu

Hua Eleanor Yu

Billy and Audrey Wilder Endowed Professor

City of Hope Comprehensive Cancer Center

Jadwiga Bienkowska

Jadwiga Bienkowska

Sr. Director, Computational Biology ORD

Pfizer

Jean-Marie Bruey

Jean-Marie Bruey

Vice President, Translational Medicine

GossamerBio

Jeffrey Skolnik

Jeffrey Skolnik

Vice President, Clinical Development

Inovio Pharmaceuticals

Jeffrey Wallin

Senior Director, Biomarker Sciences

Gilead

Joanne Tan

Joanne Tan

Director

Nkarta Therapeutics

John Lu

John Lu

CSO

HebeCell Corporation

John Rossi

Head of Translational Medicine, SVP Research

Cero Therapeutics

Katherine Call

Katherine Call

Former Senior Director

Sanofi

Ken Chang

Ken Chang

Director, Clinical Biomarkers

Daiichi Sankyo

Kenneth Ramos

Kenneth Ramos

Executive Director

Texas A&M

Kevin Gergich

Kevin Gergich

Executive Director, Oncology Clinical Operations

MSD

Koustubh Ranade

Koustubh Ranade

Head of Translational Medicine at Immunocore

Immunocore

Liling Warren

Liling Warren

Director, Head of Translational Medicine Statistics

Teva Pharma

Luke Devey

Luke Devey

Vice President, Translational Sciences, Immunology

Janssen

Mark Salvati

Mark Salvati

Global Product General Manager, Amgen Oncology Early Development

Amgen

Matthew Kunicki

Matthew Kunicki

Senior Scientist

Pfizer

Michael Groaning

Michael Groaning

Global Medical Affairs Lead

Amgen

Michael Roehrl

Michael Roehrl

Director, Precision Pathology

Memorial Sloan Kettering Cancer Centre

Michelle Graham

Michelle Graham

Principal Research Scientist

AbbVie

Mike Damore

Mike Damore

Director, Translational Oncology

Pfizer

Mingchao Kang

Mingchao Kang

Group Lead, Head of Technology Platform

Ambrx

Nadia Hassounah

Nadia Hassounah

Principal Scientist, Translational Immuno-Oncology

Novartis

Nathalie Fiaschi

Nathalie Fiaschi

Director, Oncology & Angiogenesis

Regeneron

Nicole Bjorklund

Nicole Bjorklund

Director, Translational Sciences

Cohen Veterans Bioscience

Parris Pope

Parris Pope

Head of Medical Affairs

Inmune Bio

Paul Moore

Paul Moore

Vice President, Cell Biology and Immunity

Macrogenics

Philip M Arlen

Philip M Arlen

President and CEO

Precision Biologics, Inc

Pravin Kaumaya

Pravin Kaumaya

Professor and Director Vaccine Development

The Ohio State University

Russell LaMontagne

Russell LaMontagne

President and CEO

Boston Immune Technologies & Therapeutics

Sean Xie

Sean Xie

Director, Drug Safety Research & Development

Pfizer

Simi Ahmed

Simi Ahmed

Senior Vice President, Strategic Partnerships

NYSCF

Simone Filosto

Simone Filosto

Director, Cell Biology, Translational Medicine

Kite Pharma

Sonia Iyer

Sonia Iyer

Associate Director Translational Immuno-Oncology, Oncology R&D

AstraZeneca

Tauseef R. Butt

Tauseef R. Butt

President and Chief Executive Officer

Progenra

Youg Thaker

Youg Thaker

Senior Scientist

Sorrento Therapeutics

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Event Series

About

Careers

Legal

Copyright Oxford Global Marketing Limited. All rights reserved.